Setmelanotide — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-10-31 in 4mo
ESTIMATED |
READOUT
A Study of Setmelanotide in Patients With Prader-Willi Syndrome
Phase 2 · Prader-Willi Syndrome, Obesity |
RYTM RHYTHM PHARMACEUTICALS, INC. | Setmelanotide |
ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
|